DOTA-CA-170

DOTA-CA-170 is a DOTA-modified VISTA targeting agent CA-170. DOTA-CA-170 can be radiolabeled. DOTA-CA-170 can be used in the research of visualizing and distinguishing VISTA expression[1].

Product Specifications

UNSPSC

12352209

Target

Radionuclide-Drug Conjugates (RDCs) ; VISTA

Related Pathways

Antibody-drug Conjugate/ADC Related

Field of Research

Cancer

Smiles

C[C@@H](O)[C@@H](C(O)=O)NC(N[C@H](C1=NC([C@@H](NC(CN2CCN(CCN(CCN(CC2)CC(O)=O)CC(O)=O)CC(O)=O)=O)CO)=NO1)CC(N)=O)=O

Molecular Formula

C28H46N10O14

Molecular Weight

746.72

References & Citations

[1]Liu J, et al. Small-Molecule Radiotracers for Visualization of V-Domain Immunoglobulin Suppressor of T Cell Activation. J Med Chem. 2024 Oct 10;67 (19) :17690-17700.